Spire Healthcare, the UK’s biggest private hospital group, has engaged Rothschild to explore a potential sale amid pressure from major shareholders. NHS partnerships account for over 30% of its revenues, a signal that private capacity is both valuable and fragile.

Outsourcing more elective care to private providers is being sold as a solution to NHS backlogs. Yet the private sector depends on the same workforce, faces inflationary pressures, and now confronts investor demands. Contracts eat into margins, and operational stress is rising. Spire’s profits fell 50% year-on-year, citing staff cuts and tightening PMI claims.

In mental health, the trend is stark: over one in four NHS-funded inpatient beds is now delivered by independent sector providers. That shift from “surge valve” to core service carries risks to transparency, outcomes, and system sovereignty.

As independent providers’ NHS revenue jumped 16% in six months, the pressure to meet more demand intensifies. Health Service Journal This dynamic incentivises cherry-picking less complex cases, leaving the NHS to absorb the hardest and costliest work.

Patients don’t benefit from a private sector under strain or juggling a squeeze between public and private work. When the market falters, what’s left to backfill the gap? Outsourcing works only until it doesn’t, and when it fails, it’s the NHS and patients who are left covering the shortfall.